Synthetic Biologics, Inc.
BETA-LACTAMASE COMPOSITIONS FOR TREATMENT OF GRAFT VERSUS HOST DISEASE
Last updated:
Abstract:
The present invention relates to, in part, methods and compositions for reducing the incidence and/or severity of complications associated with IV beta-lactam antibiotic use in allo-HCT recipients, such as aGVHD and VRE colonization and/or VRE bloodstream infection, using beta-lactamase agents.
Status:
Application
Type:
Utility
Filling date:
5 May 2020
Issue date:
14 Jul 2022